These therapies are expected to complement current GDMT and further improve kidney and cardiovascular outcomes in patients with DKD
Op dit moment is Retatrutide nergens ter wereld officieel goedgekeurd als geneesmiddel
Sergey Terushkin, MD, FACS Tirzepatide may be prescribed for weight loss in Florida for adults with a BMI of 30+, or 27+ with weight-related conditions, after a medical evaluation
Plasma pro-C3 levels have been shown to correlate with severity of steatohepatitis and fibrosis stage in patients with MASLD 35
Our approach integrates GLP-1 into a broader, nutrition-based weight loss program
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: a retrospective analysis of the Diabetes Prospective Follow-Up Registry